Tao W, Ouyang Z, Liao Z, Li L, Zhang Y, Gao J
Cancers (Basel). 2023; 15(8).
PMID: 37190306
PMC: 10136986.
DOI: 10.3390/cancers15082378.
Llanos P, Palomero J
Cells. 2022; 11(24).
PMID: 36552772
PMC: 9776436.
DOI: 10.3390/cells11244008.
Thoma A, Earl K, Goljanek-Whysall K, Lightfoot A
J Cell Mol Med. 2022; 26(24):6032-6041.
PMID: 36426551
PMC: 9753450.
DOI: 10.1111/jcmm.17621.
Hein T, Peterson L, Bartikoski B, Portes J, Espirito Santo R, Xavier R
Arthritis Res Ther. 2022; 24(1):171.
PMID: 35854372
PMC: 9295282.
DOI: 10.1186/s13075-022-02858-y.
Graham Z, Deberry J, Cardozo C, Bamman M
Physiol Rep. 2022; 10(10):e15266.
PMID: 35611788
PMC: 9131615.
DOI: 10.14814/phy2.15266.
HY7715 Ameliorates Sarcopenia by Improving Skeletal Muscle Mass and Function in Aged Balb/c Mice.
Lee K, Kim J, Park S, Shim J, Lee J
Int J Mol Sci. 2021; 22(18).
PMID: 34576187
PMC: 8466743.
DOI: 10.3390/ijms221810023.
Transcriptome Analysis of Immune Receptor Activation and Energy Metabolism Reduction as the Underlying Mechanisms in Interleukin-6-Induced Skeletal Muscle Atrophy.
Sun H, Sun J, Li M, Qian L, Zhang L, Huang Z
Front Immunol. 2021; 12:730070.
PMID: 34552592
PMC: 8450567.
DOI: 10.3389/fimmu.2021.730070.
protein protects against TNF‑α‑induced myotube atrophy in C2C12 myotubes via the NF‑κB signaling pathway.
Lee M, Choi Y, Nam T
Mol Med Rep. 2021; 24(1).
PMID: 33955507
PMC: 8127067.
DOI: 10.3892/mmr.2021.12125.
A 50 kdyne contusion spinal cord injury with or without the drug SS-31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice.
Graham Z, Deberry J, Cardozo C, Bamman M
Physiol Rep. 2021; 9(4):e14751.
PMID: 33611851
PMC: 7897452.
DOI: 10.14814/phy2.14751.
An model using spheroids-laden nanofibrous structures for attaining high degree of myoblast alignment and differentiation.
Yeo M, Chae S, Kim G
Theranostics. 2021; 11(7):3331-3347.
PMID: 33537090
PMC: 7847672.
DOI: 10.7150/thno.53928.
Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies.
Mageriu V, Manole E, Bastian A, Staniceanu F
J Immunol Res. 2020; 2020:9079083.
PMID: 32775472
PMC: 7396002.
DOI: 10.1155/2020/9079083.
Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.
Tse B, Dvoriantchikova G, Tao W, Gallo R, Lee J, Ivanov D
Exp Eye Res. 2020; 199:108178.
PMID: 32758490
PMC: 7554259.
DOI: 10.1016/j.exer.2020.108178.
Targeting reactive oxygen species (ROS) to combat the age-related loss of muscle mass and function.
Thoma A, Akter-Miah T, Reade R, Lightfoot A
Biogerontology. 2020; 21(4):475-484.
PMID: 32447556
PMC: 7347670.
DOI: 10.1007/s10522-020-09883-x.
The mitochondrial antioxidant SS-31 increases SIRT1 levels and ameliorates inflammation, oxidative stress and leukocyte-endothelium interactions in type 2 diabetes.
Escribano-Lopez I, Diaz-Morales N, Iannantuoni F, Lopez-Domenech S, de Maranon A, Abad-Jimenez Z
Sci Rep. 2018; 8(1):15862.
PMID: 30367115
PMC: 6203778.
DOI: 10.1038/s41598-018-34251-8.
Age-related changes in skeletal muscle: changes to life-style as a therapy.
McCormick R, Vasilaki A
Biogerontology. 2018; 19(6):519-536.
PMID: 30259289
PMC: 6223729.
DOI: 10.1007/s10522-018-9775-3.
Redox homeostasis and age-related deficits in neuromuscular integrity and function.
Sakellariou G, Lightfoot A, Earl K, Stofanko M, McDonagh B
J Cachexia Sarcopenia Muscle. 2017; 8(6):881-906.
PMID: 28744984
PMC: 5700439.
DOI: 10.1002/jcsm.12223.
Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.
Chiu L, Anderton R, Knuckey N, Meloni B
Mol Neurobiol. 2016; 54(10):7838-7857.
PMID: 27844291
DOI: 10.1007/s12035-016-0287-3.
Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy.
Sakellariou G, Pearson T, Lightfoot A, Nye G, Wells N, Giakoumaki I
Sci Rep. 2016; 6:33944.
PMID: 27681159
PMC: 5041117.
DOI: 10.1038/srep33944.